US Energy Supplement Recalled Over Erectile Dysfunction Medication Presence
The US Food and Drug Administration (FDA) has announced a voluntary recall of an energy supplement sold online due to its potential presence of an unapproved erectile dysfunction medication, Tadalafil.
Tadalafil, commonly known as "the weekend pill," can last for up to 36 hours, significantly longer than the 4-hour duration of Viagra. Akkarco LLC, the manufacturer of Ashfiat Alharamain Energy Support, has stopped non-prescription sales and urges customers who purchased the product to stop using it immediately.
According to the FDA, Tadalafil was detected in the supplement through testing, which is an unapproved new drug. The agency notes that the safety and efficacy of the supplement have not been established. The recall covers a batch with a specific lot number and expiration date, packaged in a glass bottle with an orange label, distributed nationwide online.
Akkrco's spokesperson stated that sales of the affected batch were limited and distribution was halted after the issue was identified. The company is now working to ensure future distribution meets prescription requirements and FDA regulations.
Customers are advised to stop using the supplement immediately and either throw it out or return it to the original seller. Anyone experiencing an adverse reaction can report it online.
The recall serves as a reminder of the risks associated with unapproved medications in dietary supplements, particularly those that interact with other substances or have side effects similar to prescription medications.
The US Food and Drug Administration (FDA) has announced a voluntary recall of an energy supplement sold online due to its potential presence of an unapproved erectile dysfunction medication, Tadalafil.
Tadalafil, commonly known as "the weekend pill," can last for up to 36 hours, significantly longer than the 4-hour duration of Viagra. Akkarco LLC, the manufacturer of Ashfiat Alharamain Energy Support, has stopped non-prescription sales and urges customers who purchased the product to stop using it immediately.
According to the FDA, Tadalafil was detected in the supplement through testing, which is an unapproved new drug. The agency notes that the safety and efficacy of the supplement have not been established. The recall covers a batch with a specific lot number and expiration date, packaged in a glass bottle with an orange label, distributed nationwide online.
Akkrco's spokesperson stated that sales of the affected batch were limited and distribution was halted after the issue was identified. The company is now working to ensure future distribution meets prescription requirements and FDA regulations.
Customers are advised to stop using the supplement immediately and either throw it out or return it to the original seller. Anyone experiencing an adverse reaction can report it online.
The recall serves as a reminder of the risks associated with unapproved medications in dietary supplements, particularly those that interact with other substances or have side effects similar to prescription medications.